GlassScriptPhysician profile
Ema Avdagic
NPI 1497287148
$17,278.50
in general payments reported to CMS, 2019-2025
15 companies · $3,014 in 2025
The $3,014 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $167 · 2023: $589 · 2024: $14K · 2025: $3,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,328 · Consulting Fee: $3,980 · Food and Beverage: $3,731 · Travel and Lodging: $2,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,328.22 |
| Consulting Fee | $3,980.00 |
| Food and Beverage | $3,731.21 |
| Travel and Lodging | $2,072.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $8,068.40 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $6,825.45 | 2024-2025 | Idose, Travoprost Intraocular Implant - Idose, Idosetr |
| Alcon Vision LLC | $659.24 | 2023-2025 | Rocklatan, Clareon, Hydrus Microstent |
| Abbvie INC. | $542.27 | 2023-2025 | Durysta, Xen Glaucoma Treatment System |
| New World Medical,INC. | $387.88 | 2022-2025 | Ahmed Glaucoma Valve, Streamline, Clearpath |
| Carl Zeiss Meditec, INC. | $146.04 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $138.88 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $137.16 | 2023-2025 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $109.09 | 2023 | Tecnis Iol, Tecnis Iol, Veritas Vision System |
| Nova Eye, INC. | $86.16 | 2024 | |
| Rayner Intraocular Lenses Limited | $59.65 | 2024 | Omidria, Rayone Emv, Rayone Aspheric |
| Bausch & Lomb Americas INC. | $41.32 | 2023-2025 | Envista Envy Iol, Envista Mx60 Iol |
| Harrow Eye, LLC | $27.82 | 2024 | Vevye |
| Rxsight INC | $24.83 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Regeneron Healthcare Solutions, INC. | $24.31 | 2023 | Eylea |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ema Avdagic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.